Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma
-
Published:2024-03
Issue:
Volume:Volume 11
Page:455-461
-
ISSN:2253-5969
-
Container-title:Journal of Hepatocellular Carcinoma
-
language:en
-
Short-container-title:JHC
Author:
Chamseddine Shadi,
LaPelusa Michael,
Xiao Lianchun,
Mohamed YehiaORCID,
Lee Sunyoung,
Hu Zishuo,
Hatia RikitaORCID,
Hassan Manal,
Yao JamesORCID,
Duda Dan,
Datar Saumil,
Amin HeshamORCID,
Kaseb Ahmed
Publisher
Informa UK Limited